Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Apatinib in Combination With Docetaxel for Patients With Advanced NSCLC After Failure of Platinum-based Double-drug Therapy

NCT03411967 is registered in ClinicalTrials.gov with Zigong No.1 Peoples Hospital as lead sponsor.

NCT NCT03411967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03411967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Apatinib in Combination With Docetaxel for Patients With Advanced NSCLC After Failure of Platinum-based Double-drug Therapy
Lead sponsor
Zigong No.1 Peoples Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
February 1, 2018
Completion date
December 1, 2021
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer